Raghav Aggarwal is named as a lobbyist on federal disclosure filings for 52 clients through Bgr Government Affairs. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Pharmacy, Medicare/Medicaid and Veterans.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| STRYKER CORPORATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| MATRIX MEDICAL NETWORK | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| BREAKTHROUGH T1D (F/K/A JDRF) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| APPLIED BIOLOGICS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| NYU LANGONE HEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| ACADEMY OF NUTRITION AND DIETETICS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| SCP-HEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| AKEBIA THERAPEUTICS, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| ESSILORLUXOTTICA (FKA ESSILOR OF AMERICA, INC.) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Government Issues |
| BAYER CORPORATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| AMERICAN SOCIETY OF GENE AND CELL THERAPY | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| WALGREEN CO. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| EDWARDS LIFESCIENCES LLC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| CARDINAL HEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues |
| CENTENE CORPORATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| NEUROCRINE BIOSCIENCES, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| LOCKTON MANAGEMENT, LLC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| SENIOR CARE PHARMACY COALITION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| WAYSTAR | BGR GOVERNMENT AFFAIRS | Q3 2026 | Science/Technology, Health Issues |
| AMERICAN HEALTH CARE ASSOCIATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medicare/Medicaid |
| ALKERMES, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| NOVARTIS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medicare/Medicaid, Health Issues |
| FRESENIUS MEDICAL CARE NORTH AMERICA (FKA FRESENIUS MEDICAL CARE) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| INDUCTIVEHEALTH INFORMATICS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| REGENERON PHARMACEUTICALS, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| INTERSYSTEMS PUBLIC SECTOR CORPORATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Veterans, Health Issues |
| PFIZER, INC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| AMGEN INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| GLAXOSMITHKLINE, INC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| PREMIA SPINE | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medical/Disease Research/Clinical Labs |
| PHI HEALTH, LLC, D/B/A PHI AIR MEDICAL | BGR GOVERNMENT AFFAIRS | Q3 2026 | Insurance, Health Issues |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| WELBEHEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| ICF CONSULTING GROUP, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Government Issues |
| MONTANA HEALTH SOLUTIONS, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medicare/Medicaid, Health Issues |
| DELCATH SYSTEMS, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| BECTON, DICKINSON AND COMPANY | BGR GOVERNMENT AFFAIRS | Q3 2026 | Tariff (miscellaneous tariff bills) |
| HELLO HEART, INC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| PEPSICO, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.) |
| NATIONAL ALLIANCE FOR CARE AT HOME | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| ALLIANCE FOR REGENERATIVE MEDICINE | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| REAL TIME MEDICAL SYSTEMS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| OAK STREET HEALTH D/B/A CVS HEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| TRANSMEDICS | BGR GOVERNMENT AFFAIRS | Q1 2026 | Health Issues |
| SWORD HEALTH | BGR GOVERNMENT AFFAIRS | Q1 2026 | Health Issues |
| QUOTE VELOCITY | BGR GOVERNMENT AFFAIRS | Q4 2025 | Medicare/Medicaid |
| DIGNITY AND WELLNESS PATIENT SOLUTIONS, LLC | BGR GOVERNMENT AFFAIRS | Q3 2025 | Health Issues |
| SELECT MEDICAL CORPORATION | BGR GOVERNMENT AFFAIRS | Q3 2025 | Medicare/Medicaid |
| AMERICAN ASSOCIATION OF NURSE ANESTHESIOLOGY | BGR GOVERNMENT AFFAIRS | Q1 2025 | Veterans, Health Issues, Budget/Appropriations |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 48 | 1 |
| 2025 | 34 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 15 | $17K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Raghav Aggarwal. See the Capitol Clarity rankings and method.